Indeed, increased levels of DCLRE1C/Artemis, DNA–PKcs, and XRCC4 proteins were observed in MM cells, while elevated expressions of XRCC5 and DCLRE1C/Artemis genes were linked to poorer prognosis in MM patients [46]. This evidence concerns the gene XRCC4 and Miyoshi myopathy.